T-CELL LYMPHOMA REFRACTORY

This adverse event was reported 35 times

T-CELL LYMPHOMA REFRACTORY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DUVELISIB 4 0.0047
1 MESNA INJECTION 11 0.0013
2 MESNA 11 0.0013
3 ETOPOSIDE PHOSPHATE 2 0.0012
4 IFOSFAMIDE FOR INJECTION 25 0.0012
5 ETOPOSIDE 24 0.0003
6 DOXORUBICIN 12 0.0001
7 DOXORUBICIN HYDROCHLORIDE 4 0.0001
8 CARBOPLATIN 15 0.0001
9 FILGRASTIM 3 0.0001
See all drugs enriched for association with T-CELL LYMPHOMA REFRACTORY